Dr. Hongjian Qin | Organic Chemistry | Best Researcher Award

Published on by Chemistry Awards

Dr. Hongjian Qin | Organic Chemistry | Best Researcher Award

Dr. Hongjian Qin , Shanghai Institute of Materia Medica, CAS , China

Dr. Hongjian Qin is an accomplished researcher in sustainable and green chemistry, with expertise in drug process development and medicinal administration. He earned his Ph.D. in Organic Chemistry from the Chinese Academy of Sciences, being recognized as an Excellent Graduate in 2024. Dr. Hongjian Qin’s contributions to the field span over three years, emphasizing environmentally friendly pharmaceutical synthesis and active pharmaceutical ingredient (API) development. Currently serving as Research Director at Topharman Company Limited, he continues to advance innovative solutions in drug development. His work includes mentoring students, enhancing resource recovery, and participating in COVID-19 research. With numerous impactful publications, Dr. Hongjian Qin is a dedicated professional committed to promoting sustainability and advancing solutions for global environmental challenges.

Professional Profile:

Scopus 

Summary of Suitability for Award:

Dr. Hongjian Qin is an exemplary candidate for the “Best Researcher Awards,” with a distinguished career in sustainable and green chemistry. His pioneering research in eco-friendly pharmaceutical synthesis has significantly contributed to reducing industrial waste and enhancing process efficiency, aligning with global sustainability objectives. Dr. Hongjian Qin’s innovative work on ligand-free catalysis, large-scale API production, and impurity profiling reflects his expertise in developing practical solutions for complex challenges in organic chemistry and medicinal chemistry. Dr. Hongjian Qin’s research excellence, innovative contributions, and global impact make him a highly deserving candidate for the “Best Researcher Awards.” His work not only addresses critical scientific challenges but also fosters sustainable practices in drug development, making a lasting impact on both academia and industry.

🎓Education:

Dr. Hongjian Qin holds a Ph.D. in Organic Chemistry from the Chinese Academy of Sciences , specializing in process development of drug substances and medicinal administration. His doctoral work was conducted at the Key Laboratory of Plant Resources and Chemistry in Arid Regions, showcasing expertise in sustainable pharmaceutical synthesis. He completed a Master of Engineering in Organic Chemistry from Guangxi University, focusing on the process development of drug substances. Dr. Qin’s academic journey began with a Bachelor of Science in Organic Chemistry from Guangxi University . His educational foundation combines rigorous theoretical knowledge with practical applications, preparing him to address complex challenges in green and sustainable chemistry.

🏢Work Experience:

Dr. Hongjian Qin’s professional journey spans over a decade, focusing on pharmaceutical synthesis and sustainable chemistry. As Research Director at Topharman Company Limited (2024–present), he spearheads innovations in active pharmaceutical ingredients (APIs) and emphasizes good manufacturing practices (GMP). Previously, as a Research Assistant at the Shanghai Institute of Materia Medica (2021–2024), he supported COVID-19 research projects, trained students, and enhanced pharmaceutical waste recovery techniques. At the Xinjiang Engineering Research Centre for Key Technologies and Processes of Ethnomedicine (2015–2021), Dr. Hongjian Qin led projects on sustainable API production and industrial resource recovery. His experiences reflect a blend of academic research and industrial application, driving advancements in pharmaceutical science.

🏅Awards: 

Dr. Hongjian Qin has received numerous accolades for his contributions to sustainable chemistry. He was honored as an Excellent Graduate in 2024 by the University of Chinese Academy of Sciences for his outstanding academic achievements during his Ph.D. studies. His work on sustainable pharmaceutical synthesis earned him recognition at various national and international conferences. Dr. Hongjian Qin has been instrumental in developing innovative processes for drug substances, garnering appreciation from industrial partners. Additionally, his mentorship roles and administrative contributions at research institutions have been commended, underscoring his commitment to advancing science and education.

🔬Research Focus:

Dr. Hongjian Qin’s research focuses on sustainable and green chemistry, particularly in the process development of drug substances. He has worked extensively on optimizing synthesis methods for pharmaceutical intermediates, reducing waste, and improving efficiency in drug manufacturing. His innovative approaches emphasize the use of eco-friendly reagents and catalysts, aligning with global sustainability goals. His recent work includes developing ligand-free copper-catalyzed cyclization methods, novel iron-catalyzed cross-coupling reactions, and efficient large-scale processes for active pharmaceutical ingredients (APIs). Dr. Hongjian Qin is dedicated to advancing environmentally responsible techniques in pharmaceutical synthesis, ensuring both industrial viability and ecological preservation.

Publication Top Notes:

1. Direct Esterification of Amides by the Dimethylsulfate-Mediated Activation of Amide C–N Bonds

Authors: Qin, H.; Han, Z.; Bonku, E.M.; Shen, J.; Aisa, H.A.

Year: 2024

Citations: 0

2. An Alternative Approach to Synthesize Sildenafil via Improved Copper-Catalyzed Cyclization

Authors: Odilov, A.; Gong, X.; Qin, H.; Yang, F.; Shen, J.

Year: 2024

Citations: 0

3. Impurity Study of Tecovirimat (Open Access)

Authors: Bonku, E.M.; Qin, H.; Odilov, A.; Wang, X.; Shen, J.

Year: 2024

Citations: 1

4. Improved and Ligand-Free Copper-Catalyzed Cyclization for an Efficient Synthesis of Benzimidazoles from o-Bromoarylamine and Nitriles (Open Access)

Authors: Bonku, E.M.; Qin, H.; Odilov, A.; Aisa, H.A.; Shen, J.

Year: 2024

Citations: 2

5. Direct Reductive N-Alkylation of Amines with Carboxylic Esters

Authors: Zhang, Y.; Bonku, E.M.; Yang, X.; Shen, J.; Qin, H.

Year: 2024 (In Press)

Citations: 0

6. Iron-Catalyzed Cross-Coupling Reactions of Alkyl Grignard Reagents with Alkenyl Carbonate

Authors: Qin, H.; Yang, X.; Mintah Bonku, E.; Shen, J.; Akber Aisa, H.

Year: 2024 (In Press)

Citations: 0

7. A Review of the Synthetic Strategies Toward the Antiviral Drug Tecovirimat (Review Article)

Authors: Bonku, E.M.; Qin, H.; Odilov, A.; Zhu, F.; Shen, J.

Year: 2024 (In Press)

Citations: 0

8. An Improved Iodine-Catalyzed Aromatization Reaction and Its Application in the Synthesis of a Key Intermediate of Cannabidiol

Authors: Abduahadi, S.; Bonku, E.M.; Qin, H.; Aisa, H.A.; Shen, J.

Year: 2024 (In Press)

Citations: 0

9. Optimized Synthesis of the Key Intermediate of Telmisartan via the Cyclization of 2-Bromoarylamine with n-Butyronitrile

Authors: Qin, H.; Mintah Bonku, E.; Odilov, A.; Zhu, F.; Aisa, H.A.

Year: 2023

Citations: 1

10. Efficient Large-Scale Process for Tecovirimat via Reactive Distillation for the Preparation of Cycloheptatriene

Authors: Bonku, E.M.; Qin, H.; Odilov, A.; Guma, S.D.; Shen, J.

Year: 2023

Citations: 4

 

 

 

 

 

Mei luo | Organic and organometallic chemistry | Best Researcher Award

Published on by Chemistry Awards

Prof. Mei luo | Organic and organometallic chemistry | Best Researcher Award

Professor at Hefei university of technology, China 

Dr. Mei Luo is currently serving as an Associate Professor at Hefei University of Technology, bringing a wealth of experience in organic and organometallic chemistry. She obtained her Ph.D. from the University of Science and Technology of China and pursued postdoctoral research at prestigious institutions such as Peking University, the University of Utah, and the University of North Carolina at Chapel Hill. With a strong focus on synthesizing chiral organometallic complexes and drug synthesis, Dr. Luo has contributed significantly to the field through innovative research and academic endeavors.

Author Metrics

Scopus Profile

ORCID Profile

Dr. Mei Luo has achieved notable recognition in academia, boasting over 200 patents since 2006. Her research has been extensively published in reputable journals, highlighting her impact in the areas of metal complex synthesis, characterization, and their applications in medicinal chemistry and catalysis. Her publications reflect a strong interdisciplinary approach, integrating theoretical and experimental methodologies to advance the understanding and application of organometallic chemistry.

Dr. Mei Luo, currently affiliated with Hefei University of Technology in Hefei, China, has a notable academic profile. According to Scopus Author Identifier, her research has garnered 248 citations from 224 documents, with an h-index of 9. She has authored 62 documents indexed in Scopus, reflecting her significant contributions to the field of organic and organometallic chemistry. For more detailed metrics and information, accessing her full profile via Scopus or ORCID would provide comprehensive insights into her research impact and academic achievements.

Education

Dr. Luo earned her M.S. in Chemistry from Hefei University of Technology and completed her Ph.D. at the University of Science and Technology of China. Her academic journey also includes postdoctoral fellowships at Peking University, the University of Utah, and the University of North Carolina at Chapel Hill, where she further honed her expertise in organic and organometallic chemistry.

Research Focus

Dr. Mei Luo’s research primarily revolves around the synthesis of chiral organometallic complexes and drug synthesis. She has made significant contributions to understanding the structural and functional properties of metal complexes, particularly their applications in medicinal chemistry, catalysis, and molecular docking studies.

Professional Journey

Beginning with her educational background, Dr. Luo’s professional journey spans multiple prestigious institutions and positions. After completing her Ph.D., she conducted postdoctoral research at Peking University, the University of Utah, and the University of North Carolina at Chapel Hill. Currently, she serves as an Associate Professor at Hefei University of Technology, where she continues to lead research and mentor students in organic and organometallic chemistry.

Honors & Awards

Dr. Mei Luo has received recognition for her contributions to organic and organometallic chemistry, although specific awards and honors were not detailed in the provided information. Her extensive publication record and patent portfolio underscore her achievements and impact within her field of expertise.

Publications Noted & Contributions

Dr. Luo has authored numerous influential publications, focusing on metal complexes with biological applications. Notable publications include studies on the synthesis, characterization, and biological activities of Zn (II), Cu (II), Co (II), and Ni (II) complexes bearing aza-heterocyclic ligands, as well as their antitumor effects. Her research contributions extend to structural investigations, Hirshfeld surface analyses, and quantum mechanical studies of various organometallic compounds.

Mei Luo has authored several notable books and publications, including:

Zn (II), Cu (II), Co (II), and Ni (II) complexes bearing aza-heterocyclic ligands: synthesis, characterization, and anticancer activities

  • Journal: Journal of the Iranian Chemical Society
  • Date: 2024-06
  • DOI: 10.1007/s13738-024-03021-x
  • Contributors: Amir Nazeer, Qasim Umar, Yanting Yang, Mei Luo

A Brief Review: Advancement in the Synthesis of Amine through the Leuckart Reaction

Synthesis, characterization and anticancer activities of Zn2+, Cu2+, Co2+ and Ni2+ complexes involving chiral amino alcohols

  • Journal: RSC Advances
  • Date: 2022
  • DOI: 10.1039/D2RA05576G
  • Contributors: Qasim Umar, Y. H. Huang, Amir Nazeer, Hao Yin, Jing Cheng Zhang, Mei Luo, X. G. Meng

Correction to: One-step templated synthesis of chiral organometallic salicyloxazoline complexes

  • Journal: BMC Chemistry
  • Date: 2019-05-10
  • DOI: 10.1186/s13065-019-0577-8
  • Contributors: Mei Luo, Jing Cheng Zhang, Hao Yin, Cheng Ming Wang, Susan Morris-Natschke, Kuo-Hsiung Lee

One-step templated synthesis of chiral organometallic salicyloxazoline complexes

  • Journal: BMC Chemistry
  • Date: 2019-04-04
  • DOI: 10.1186/s13065-019-0565-z
  • Contributors: Mei Luo, Jing Cheng Zhang, Hao Yin, Cheng Ming Wang, Susan Morris-Natschke, Kuo-Hsiung Le

Research Timeline

Dr. Mei Luo’s research journey began with her doctoral studies at the University of Science and Technology of China, followed by postdoctoral research positions at Peking University, the University of Utah, and the University of North Carolina at Chapel Hill. Since joining Hefei University of Technology as an Associate Professor, she has continued to expand her research focus on chiral organometallic complex synthesis and drug synthesis, publishing extensively in respected scientific journals.

2024:

  1. Zn (II), Cu (II), Co (II), and Ni (II) complexes bearing aza-heterocyclic ligands: synthesis, characterization, and anticancer activities
    • This study focused on synthesizing and characterizing metal complexes with aza-heterocyclic ligands. It explored their potential anticancer activities, contributing to the field of medicinal chemistry and organometallic complexes.

2023:

  1. 一Research progress on one-pot synthesis of oxazoline metal complexes
    • This publication (translated as “Progress in One-Pot Synthesis of Oxazoline Metal Complexes”) discussed advancements in the one-pot synthesis method for creating oxazoline metal complexes, emphasizing efficiency and innovation in synthetic organic chemistry.
  2. Combining Effect of Zn2+, Cu2+, Co2+, and Ni2+ Complexes Containing Chiral Amino Alcohols: Synthesis, Characterization and their Anticancer Activities
    • This research delved into the synthesis and characterization of metal complexes containing chiral amino alcohols. It investigated their combined effects and anticancer activities, contributing valuable insights into the potential therapeutic applications of these complexes.

These recent achievements highlight Mei Luo’s ongoing contributions to the fields of organic synthesis, organometallic chemistry, and medicinal chemistry, particularly focusing on innovative synthesis methods and the development of compounds with significant biological activities.

Collaborations and Projects

Dr. Luo actively collaborates with researchers both nationally and internationally, enhancing her research impact and fostering interdisciplinary approaches in organic and organometallic chemistry. Her collaborations encompass projects that explore novel synthesis methodologies, structural characterization techniques, and the biological applications of metal complexes, contributing to advancements in medicinal chemistry and catalysis.